These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28847068)

  • 1. [A new perspective of survival data on clinical epidemiology: introduction of competitive risk model].
    Nie ZQ; Ou YQ; Qu YJ; Yuan HY; Liu XQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Aug; 38(8):1127-1131. PubMed ID: 28847068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to the Analysis of Survival Data in the Presence of Competing Risks.
    Austin PC; Lee DS; Fine JP
    Circulation; 2016 Feb; 133(6):601-9. PubMed ID: 26858290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the Cox model to the Fine-Gray model for survival analyses of re-fracture rates.
    Nolan EK; Chen HY
    Arch Osteoporos; 2020 Jun; 15(1):86. PubMed ID: 32519193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data.
    Rosthøj S; Andersen PK; Abildstrom SZ
    Comput Methods Programs Biomed; 2004 Apr; 74(1):69-75. PubMed ID: 14992828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
    de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSHREG: a SAS macro for proportional and nonproportional subdistribution hazards regression.
    Kohl M; Plischke M; Leffondré K; Heinze G
    Comput Methods Programs Biomed; 2015 Feb; 118(2):218-33. PubMed ID: 25572709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis.
    Schuster NA; Hoogendijk EO; Kok AAL; Twisk JWR; Heymans MW
    J Clin Epidemiol; 2020 Jun; 122():42-48. PubMed ID: 32165133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling two cause-specific hazards of competing risks in one cumulative proportional odds model?
    Ohneberg K; Schumacher M; Beyersmann J
    Stat Med; 2017 Nov; 36(27):4353-4363. PubMed ID: 28833435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
    Rauch G; Kieser M; Ulrich S; Doherty P; Rauch B; Schneider S; Riemer T; Senges J
    Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical recommendations for reporting Fine-Gray model analyses for competing risk data.
    Austin PC; Fine JP
    Stat Med; 2017 Nov; 36(27):4391-4400. PubMed ID: 28913837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.
    Lacny S; Wilson T; Clement F; Roberts DJ; Faris PD; Ghali WA; Marshall DA
    Clin Orthop Relat Res; 2015 Nov; 473(11):3431-42. PubMed ID: 25804881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dealing with competing risks: testing covariates and calculating sample size.
    Pintilie M
    Stat Med; 2002 Nov; 21(22):3317-24. PubMed ID: 12407674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring.
    Geskus RB
    Biometrics; 2011 Mar; 67(1):39-49. PubMed ID: 20377575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tree-based models for survival data with competing risks.
    Kretowska M
    Comput Methods Programs Biomed; 2018 Jun; 159():185-198. PubMed ID: 29650312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent covariates in the proportional subdistribution hazards model for competing risks.
    Beyersmann J; Schumacher M
    Biostatistics; 2008 Oct; 9(4):765-76. PubMed ID: 18434297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When do we need competing risks methods for survival analysis in nephrology?
    Noordzij M; Leffondré K; van Stralen KJ; Zoccali C; Dekker FW; Jager KJ
    Nephrol Dial Transplant; 2013 Nov; 28(11):2670-7. PubMed ID: 23975843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accounting for Competing Events When Evaluating Long-Term Outcomes in Survivors of Critical Illness.
    Angriman F; Ferreyro BL; Harhay MO; Wunsch H; Rosella LC; Scales DC
    Am J Respir Crit Care Med; 2023 Dec; 208(11):1158-1165. PubMed ID: 37769125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accounting for competing risks in randomized controlled trials: a review and recommendations for improvement.
    Austin PC; Fine JP
    Stat Med; 2017 Apr; 36(8):1203-1209. PubMed ID: 28102550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.